Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Kramer

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
International Journal of Cancer|March 20, 2014
Key role for myeloid cells: phase II results of anti-G(D2) antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastomaNai-Kong V Cheung, Irene Y Cheung, Kim Kramer, et al.
Cancer|March 3, 2015
Osteochondroma in long-term survivors of high-risk neuroblastomaBrian H Kushner, Stephen S Roberts, Danielle N Friedman, et al.
Pediatric Neurosurgery|January 22, 2004
Treatment of spinal involvement in neuroblastoma patientsDavid I Sandberg, Mark H Bilsky, Brian H Kushner, et al.
Oncotargets and Therapy|December 10, 2015
Incidence and clinical significance of ESR1 mutations in heavily pretreated metastatic breast cancer patientsJiaxin Niu, Grant Andres, Kim Kramer, et al.
Journal of Neuro-Oncology|May 7, 2015
Low incidence of radionecrosis in children treated with conventional radiation therapy and intrathecal radioimmunotherapyKim Kramer, Neeta Pandit-Taskar, Pat Zanzonico, et al.
Oncotarget|December 2, 2015
Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoinBrian H Kushner, Irina Ostrovnaya, Irene Y Cheung, et al.
Pediatric Blood & Cancer|February 17, 2005
Long-term complications in survivors of advanced stage neuroblastomaCaroline Laverdière, Nai-Kong V Cheung, Brian H Kushner, et al.
International Journal of Cancer|March 26, 2018
Treatment and outcome of adult-onset neuroblastomaMaya Suzuki, Brian H Kushner, Kim Kramer, et al.
Oncotarget|December 10, 2017
<i>MYCN</i>-amplified stage 2/3 neuroblastoma: excellent survival in the era of anti-G<sub>D2</sub> immunotherapyBrian H Kushner, Michael P LaQuaglia, Shakeel Modak, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 13, 2020
IntraOmmaya compartmental radioimmunotherapy using <sup>131</sup>I-omburtamab-pharmacokinetic modeling to optimize therapeutic indexRahul S Yerrabelli, Ping He, Edward K Fung, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
International Journal of Cancer|March 20, 2014
Key role for myeloid cells: phase II results of anti-G(D2) antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastomaNai-Kong V Cheung, Irene Y Cheung, Kim Kramer, et al.
Cancer|March 3, 2015
Osteochondroma in long-term survivors of high-risk neuroblastomaBrian H Kushner, Stephen S Roberts, Danielle N Friedman, et al.
Pediatric Neurosurgery|January 22, 2004
Treatment of spinal involvement in neuroblastoma patientsDavid I Sandberg, Mark H Bilsky, Brian H Kushner, et al.
Oncotargets and Therapy|December 10, 2015
Incidence and clinical significance of ESR1 mutations in heavily pretreated metastatic breast cancer patientsJiaxin Niu, Grant Andres, Kim Kramer, et al.
Journal of Neuro-Oncology|May 7, 2015
Low incidence of radionecrosis in children treated with conventional radiation therapy and intrathecal radioimmunotherapyKim Kramer, Neeta Pandit-Taskar, Pat Zanzonico, et al.
Oncotarget|December 2, 2015
Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoinBrian H Kushner, Irina Ostrovnaya, Irene Y Cheung, et al.
Pediatric Blood & Cancer|February 17, 2005
Long-term complications in survivors of advanced stage neuroblastomaCaroline Laverdière, Nai-Kong V Cheung, Brian H Kushner, et al.
International Journal of Cancer|March 26, 2018
Treatment and outcome of adult-onset neuroblastomaMaya Suzuki, Brian H Kushner, Kim Kramer, et al.
Oncotarget|December 10, 2017
<i>MYCN</i>-amplified stage 2/3 neuroblastoma: excellent survival in the era of anti-G<sub>D2</sub> immunotherapyBrian H Kushner, Michael P LaQuaglia, Shakeel Modak, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 13, 2020
IntraOmmaya compartmental radioimmunotherapy using <sup>131</sup>I-omburtamab-pharmacokinetic modeling to optimize therapeutic indexRahul S Yerrabelli, Ping He, Edward K Fung, et al.
Pageof 11